PURA - Puration Plans To Issue Dividends In Cannabis Extraction Subsidiary With Facilities To Be Built In California And Canada
03 January 2018 - 2:27AM
InvestorsHub NewsWire
Dallas, TX -- January 2,
2018 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced plans to issue stock in a new subsidiary
dedicated to cannabis extraction with extraction facilities to be
built in California and Canada in conjunction with new recreational
marijuana legalization laws in both locations. The company
anticipates building multiple extraction facilities in more than
one location in both regions and expanding to additional
regions. Puration is the sole licensee to U.S. Patent No.
9,199,960, entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS
PLANT MATERIALS INCLUDING THE CANNABIS PLANT." The license
permits Puration to produce cannabis extracts for infusion into
recreational, fitness wellness, alternative medicine and beauty
products. Puration recently announced plans to launch new
cannabis infused beverage lines into Canada’s legal $8 billion
market in addition to announcing plans to open a
cannabis extraction facility into California’s legal $10 billion
market. Puration’s extraction capacity is being
structured into a new subsidiary in a first step to
unlock shareholder
value by delineating between the company’s patented
extraction business and cannabis infused beverage business.
The Company plans to release this Thursday, January 4th,
more details on the strategy to build an extraction subsidiary and
issue stock in the subsidiary to shareholders of
Puration.
For more information on Puration visit www.aciconglomerated.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within
the meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any disease.
For More Information Contact:
Brian Shibley,
info@aciconglomerated.com
1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2024 to May 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Puration Inc (CE) (OTCMarkets): 0 recent articles
More Puration Inc. (PC) News Articles